Takeda, Lilly Rejected by Supreme Court on Actos Fraud Lawsuit
The U.S. Supreme Court denied Takeda Pharmaceutical and Eli Lilly’s request to block a racketeering lawsuit, allowing a class action alleging the companies concealed Actos’s link to bladder cancer to proceed. The suit targets tens of thousands of insurers and other third‑party payers who covered millions of prescriptions. Potential liability could reach multibillion‑dollar levels, echoing Takeda’s 2015 $2.37 billion settlement over similar claims. Business groups view the ruling as a pivotal test of class‑action limits for the pharmaceutical sector.
Imaging Interoperability Offers a Lifeline to Rural Hospitals and the Patients Depending on Them
Rural hospitals, already strained by shrinking Medicaid enrollment and decades of closures, now face an acute threat: 315 facilities are at immediate risk of shutting down and another 450 are in serious jeopardy. A core driver of this crisis is...
New Hope For Spina Bifida
A new prenatal therapy combining in‑utero surgery with placental stem‑cell patches, tested in the CuRe trial, has shown promising safety results for spina bifida. Six pregnancies underwent the procedure between 19 and 26 weeks, all delivering without infection, fluid leak,...
GE HealthCare Secures FDA 510(k) Clearance for Photonova Spectra Photon-Counting CT
GE HealthCare obtained FDA 510(k) clearance for Photonova Spectra, its photon‑counting CT system. The scanner uses Deep Silicon detectors with 8‑bin energy resolution, delivering simultaneous spectral and high‑definition images in a 0.23‑second rotation. NVIDIA GPU‑accelerated reconstruction handles the 50‑fold data...
Contributor: How Much? Addressing Medicines’ Cost and Value
The article argues that drug pricing debates must focus on aligning prices with the full value medicines deliver to patients and society. It critiques current health technology assessment (HTA) practices for using narrow benefit definitions, which can depress prices and...
Digital Health: Gamifying Recovery with MLB The Show 26
MLB The Show 26, Sony’s flagship baseball simulation, is being repurposed as a digital‑health tool to gamify physical and cognitive rehabilitation. By embedding reward systems, progress tracking, and multiplayer interaction, the game transforms repetitive therapy into an engaging experience. Therapists...
Choosing Alert Types For Quiet Rooms Vs High-Traffic Wards
Patient monitoring systems must align alert methods with room dynamics. In quiet patient rooms, discreet solutions such as pressure‑sensitive pads, low‑volume local alarms, pager alerts, and nurse‑call integration minimize disturbance while still notifying staff. High‑traffic wards require louder audible alarms,...
CLL/SLL Treatment Choices Based on Various Factors
A population‑based study of 148 first‑line CLL/SLL patients in Alberta found that time‑limited venetoclax‑obinutuzumab was used in 51% of cases, while continuous BTK inhibitor therapy accounted for 44%. Patients with del(17p) or TP53 mutations chose BTK inhibitors in 84% of...
Guidance Needed for Doctors Treating DOD, VA Patients Exposed to Jet Fuel in Hawaii Water, Report Says
A National Academies report finds no clinical guidance exists for treating long‑term health effects of JP‑5 jet fuel exposure, which contaminated drinking water for roughly 93,000 residents and service members in Hawaii in 2021. The study documents limited, suggestive evidence...
Samsung Medison to Unify Two U.S. Imaging Businesses as Samsung HME America
Samsung Medison announced that its two U.S. imaging units, Neurologica and Boston Imaging, will merge under the new corporate identity Samsung HME America. The consolidation brings together ultrasound, digital radiography and CT operations into a single, globally‑branded organization. Samsung says...
Reimagining Migraine Treatment: Alon Ironi of Theranica on Nerivio’s Journey to Nationwide Coverage
Theranica’s Nerivio, a remote electrical neuromodulation (REN) device, has secured nationwide coverage for roughly 130 million lives through Blue Cross Blue Shield plans. The therapy’s dual acute and preventive indications offer a drug‑free alternative that expands access to underserved groups such...
United Health Services: Talkspace Acquisition Shows The New Normal For Hybrid Healthcare
United Health Services completed the acquisition of virtual behavioral health platform Talkspace at $5.25 per share, valuing the company at roughly $835 million enterprise value. The purchase brings about 6,000 licensed clinicians into UHS’s network, directly addressing chronic staffing shortages and...
Exeter Study Explores Social Camouflaging in Acquired Brain Injury
University of Exeter researchers have launched a study to determine whether people living with acquired brain injury (ABI) employ social camouflaging strategies. Led by MSc student Faye Brookes and Associate Professor Anna Adlam, the project will use a 20‑30 minute...
PromptWell and Ellipsis Health Partner to Transform AI Patient Engagement
PromptWell and Ellipsis Health have announced a partnership that merges PromptWell’s AI‑driven timing engine with Ellipsis Health’s emotionally intelligent voice agent, Sage. The combined platform predicts the exact moment a patient is most likely to answer and then engages them...
STAT+: Pharmalittle: We’re Reading About Iran War’s Impact on Pharma Supply Chain, a Pfizer Lyme Vaccine, and More
The ongoing Iran‑Israel conflict has not yet crippled global pharmaceutical supply chains, but it threatens the modest 0.3% of worldwide drug output and 0.6% of active‑pharmaceutical‑ingredient (API) production that originates in the region. Disruptions to key shipping lanes, especially the...
Why GI Providers Should Care About That “Health Hack”
Patient dissatisfaction is driving a surge in DIY health hacks, especially in gastroenterology where one‑third of patients report avoiding care after negative experiences. Influencers promote trends like "fibermaxxing," urging excessive fiber intake that can aggravate conditions such as small intestinal...
Predicting Severe Diabetes Complications Using Administrative Claims Data in Maryland
A Maryland‑wide predictive model using Medicare fee‑for‑service claims and publicly available social‑determinant data generated risk scores for 346,614 beneficiaries, released on June 7 2024. The model retained 95 statistically significant factors out of 219 candidates and produced a mean score of 0.0124,...
Preventive Strategies to Lower Hand-Foot Syndrome Risk
Researchers published a meta‑analysis of 19 randomized trials showing that topical diclofenac gel significantly reduces the incidence of grade 2 or higher chemotherapy‑induced hand‑foot syndrome, especially in patients receiving capecitabine. The analysis also identified topical silymarin, pyridoxine 400 mg, and celecoxib as...
Somerset Indus Capital Partners Raises $288M in Fund III
Somerset Indus Capital Partners announced the closing of its third fund with $288 million in commitments, surpassing the $250 million target. The fund, backed by development finance institutions, global investors and family offices across Europe, the U.S. and Southeast Asia, will target...
Healthcare Recruiting Platform Lands $14.5M
Carefam, a conversational AI platform for healthcare staffing, emerged from stealth with a $14.5 million Series A led by Pitango HealthTech and backed by Emerge. The solution automates candidate outreach, interview scheduling, and credential verification, escalating only complex decisions to human HR...
COVID-19 Infection May Pose Greater Risks for Developing Kidney Disease Vs. Influenza
A new retrospective cohort study of over 3 million commercially insured U.S. adults found that COVID‑19 infection dramatically increases the risk of kidney complications compared with influenza. Adjusted hazard ratios show nearly double the risk of any kidney disease (HR 1.93), a...
Medicare Just Crossed $200 a Month. What It Means for Retirees
Medicare Part B premiums jumped to $202.90 a month in 2026, the first time they have cleared the $200 threshold. The Social Security cost‑of‑living adjustment added $56 to the average benefit, leaving retirees with a net gain of only about $38...
FDA Warns of Seizure Risk with some Parkinson’s Drugs
The FDA’s recent safety alert warns that high‑dose levodopa/carbidopa regimens can provoke seizures when patients develop vitamin B6 deficiency. Fourteen post‑marketing cases, including two fatalities, involved doses exceeding 1,000 mg daily and featured focal‑onset seizures that generalized. Vitamin B6 supplementation halted...
Kali Therapeutics Partners with Sanofi for KT501 in a ~$1.2B Deal
Kali Therapeutics has signed a license agreement with Sanofi granting the French giant exclusive worldwide rights to KT501, a next‑generation tri‑specific T‑cell engager aimed at B‑cell‑mediated autoimmune diseases. The deal provides Kali with $180 million in upfront and near‑term payments and...
Owner of Now-Closed Milwaukee Prenatal Care Coordination Company Sentenced to 60 Months’ Imprisonment for Healthcare Fraud Scheme
Lakia Jackson, 36, was sentenced to 60 months in federal prison for a Medicaid fraud scheme that siphoned $2.66 million intended for at‑risk pregnant women and young children in Wisconsin. She pleaded guilty to healthcare fraud and aggravated identity theft after...
Liqcreate Launches Dental Resin Designed to Eliminate Separating Agents in Orthodontic and Prosthetic Acrylic Workflows
Netherlands‑based Liqcreate has launched Separation Model, a dental photopolymer that embeds a non‑adhesive agent, removing the need for separate separating media in acrylic orthodontic and prosthetic workflows. The resin is compatible with most DLP, MSLA and laser 3‑D printers operating...
New Playbook for Private Healthcare Marketing in a Data-Driven Era
Private healthcare marketing is evolving from a standalone communications function into an integrated layer of the digital health stack, directly linked to EHRs, scheduling and telehealth platforms. This new model treats campaigns as dynamic demand‑orchestration tools that respond to real‑time...
Photon-Counting CT Better than Conventional CT in Lung Cancer
A prospective study of 200 adults compared low‑dose photon‑counting CT (PCCT) with conventional energy‑integrating detector CT for lung cancer imaging. PCCT reduced effective radiation dose by 66% (1.36 mSv vs. 4.04 mSv) and iodine load by 27%, while adverse reactions fell to...
The Future of Community-Based Healthcare Models
Community‑based healthcare is evolving from a peripheral add‑on to a primary delivery model, driven by decentralization, digital platforms, and value‑based economics. The approach embeds local clinics, health workers, and digital ecosystems to provide continuous, location‑specific care. Membership structures and managed...
Gut Health Research Is Changing Patient Care Models
Gut health research has moved from niche science to a core component of healthcare delivery. Recent FDA approval of Seres Therapeutics' Vowst and the rise of bioactive‑based microbiome products signal a shift toward industrialized, reproducible therapies. Companies across biotech, nutrition...
Henlius Receives NMPA IND Clearance for HLX18 (Biosimilar, Opdivo)
Henlius announced that China’s National Medical Products Administration (NMPA) has granted IND clearance for HLX18, a biosimilar of Opdivo (nivolumab), targeting resected solid tumours. The company also reported first‑patient dosing in Phase I trials for HLX17 (Keytruda biosimilar) and HLX13...
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Xilio Therapeutics reported a strong cash position of $137.5 million, extending its runway to the end of 2027, and highlighted significant pipeline advances. The company plans to file an IND for its bispecific PD‑1/masked IL‑2 candidate XTX501 in mid‑2026 and start...
Mobile App Development in Telehealth Matters Now More Than Ever
Telehealth has evolved from a supplemental channel into the primary interface for care delivery, driven by mature infrastructure and patient expectations. Mobile app development—especially Android due to its worldwide device penetration—has become the core conduit for patient access, provider coordination,...
Man Wins $10M Jury Verdict After ED Physicians Order Wrong Imaging Exam
A Washington man was awarded a $10 million jury verdict after emergency‑department physicians ordered the wrong imaging study, delaying treatment of a spinal epidural abscess. The misstep resulted in a 17‑hour wait, during which his paralysis progressed and became permanent. The...
STAT+: Insmed Drug Benefits Patients with Rare, Bacterial Lung Disease, Study Shows
Insmed announced that a Phase 3 trial showed adding its inhaled antibiotic Arikayce to standard therapy significantly improved respiratory symptoms and boosted culture conversion rates in patients with newly diagnosed mycobacterium avium complex (MAC) lung infection. The study met its primary...
Staten Island Boasts Best Numbers Among Troubling NYC EMS Response Times
The Independent Budget Office report shows Staten Island achieved the fastest advanced life support (ALS) EMS response in New York City in 2024, with 82% of calls answered within ten minutes. Across all boroughs, response times have slipped over the...
Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates
Avalo Therapeutics announced its 2025 financial results, reporting $98.3 million in cash and short‑term investments that should fund operations into 2028. Research and development expenses jumped to $50.1 million, driven by the Phase 2 LOTUS trial of abdakibart (AVTX‑009) for hidradenitis suppurativa. The...
Daymark Health Builds Clinical Advisory Board
Daymark Health, a Philadelphia‑based cancer‑care platform, announced the creation of a Clinical Advisory Board to steer its value‑based, full‑risk care strategy. The board brings together leading oncologists, health‑policy experts, patient advocates and former government officials, including Dr. Ezekiel Emanuel and...
STAT+: Pfizer’s Lyme Vaccine Shows Efficacy, but Misses Key Statistical Hurdle
Pfizer and Valneva’s experimental Lyme vaccine cut the risk of infection by more than 70% in a late‑stage trial, offering a promising preventive tool for a disease that affects roughly 476,000 Americans annually. The study, however, missed its primary statistical...
STAT+: Apogee Therapeutics Data Show Long-Acting Eczema Drug Induced Relief with Less Frequent Injections
Apogee Therapeutics reported that its experimental long‑acting eczema biologic, zumilokibart, achieved sustained skin‑clearance in a mid‑stage trial. Seventy‑five percent of patients receiving the drug every three months and 85 % of those dosed every six months maintained an EASI‑75 response after...
IntraBio Reports the US FDA’s sNDA Submission of Aqneursa for Ataxia-Telangiectasia
IntraBio has filed a supplemental New Drug Application (sNDA) with the U.S. FDA seeking approval of Aqneursa (levacetylleucine) for Ataxia‑Telangiectasia (A‑T). The filing is supported by a Phase III trial that met its primary and key secondary endpoints and demonstrated a...
This Serial Entrepreneur Wants The FDA To Approve His AI Doctor
Serial entrepreneur Martin Varsavsky is launching Certuma, a startup aiming to create the first FDA‑approved AI doctor. The company raised $10 million in seed funding at a $60 million valuation and is targeting 25 low‑risk conditions such as UTIs and sore throats....
Examining Clinical, Public Perceptions of Hospice, Palliative Care
Recent research highlights three critical fronts in hospice and palliative care: a Community Hospice and Palliative Medicine (CHPM) fellowship at the University of Colorado is boosting mid‑career physicians' skills and confidence to address national workforce shortages; the Canadian PEACH program...
PointClickCare Launches Next-Gen EHR for Practice Groups
PointClickCare unveiled a next‑generation electronic health record tailored for practice groups, tightly integrated with its flagship post‑acute care platform used by over 30,000 organizations. The solution embeds AI‑driven Ambient Scribe and clinical risk insights directly into physician workflows, promising measurable...
Resmed’s Global Sleep Survey Reveals Sleep Is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Resmed’s sixth Global Sleep Survey of 30,000 respondents across 13 countries shows that 53% now rank sleep as the most important health behavior, ahead of diet and exercise. Yet more than half of participants report getting quality sleep only four...
“Mid-Life Health Crisis” Hits Millennials and Gen-Xers as Private Scans Soar
Britain’s mid‑life adults (30‑59) now account for 56% of all private diagnostic scans, a six‑fold increase since 2022, driven largely by chronic pain and preventive health concerns. With NHS waiting lists exceeding two million and delays over six weeks, private...
Ex-NFL Player Convicted in $328M Genetic Testing Fraud as Medicare Scrutiny Intensifies
A Dallas federal jury convicted former NFL player Keith J. Gray of orchestrating a $328 million Medicare fraud scheme that billed for unnecessary cardiovascular genetic tests. Gray, who owned Axis Professional Labs and Kingdom Health Laboratory, was found guilty of conspiracy,...
When Voters Worry About ‘Affordability,’ Many Point to Health Care
Voters who cite affordability as their top worry are overwhelmingly pointing to health‑care costs, according to recent polling. The trend has prompted Democrats to reframe their health‑care narrative around price rather than access, using the issue to energize their base....
Risk, Readiness and Resilience
Life‑sciences firms are confronting compressed validation timelines, tighter regulatory oversight and fragile supply chains, prompting a shift from cost‑driven to confidence‑driven site selection. Middlesex County, New Jersey, offers that confidence through a highly educated talent pool, continuous university‑backed research, and deep...
Even With Dental Insurance, You Still Could Face a Large Bill
Even with dental insurance, many Americans still face sizable out‑of‑pocket bills. The article follows 65‑year‑old Russell Anthony, who expects to spend about $2,000 on dental care despite having coverage, illustrating the common "100/80/50" rule and annual benefit caps of $1,000‑$2,000....